... on Inflammatory Bowel Diseases, Jerusalem, September 10–13, 1989 D.
Rachmilewitz, George O. Zimmerman. (1) D. Rachmilewitz and J. Zimmerman (
eds.), Developments in Gastroenterology, Inflammatory Bowel Diseases 1990, ...
Author: D. Rachmilewitz
Publisher: Springer Science & Business Media
The Third International Symposium on Inflammatory Bowel Diseases was held in Jerusalem during September 10-13, 1989. Four hundred physicians and scientists from 25 countries attended the meeting. The symposium was organized into five panels devoted to state of the art reviews of the latest findings and approaches on the etiology, pathogenesis, metabolic implications, clinical assessment of disease activity and the medical management of IBD. Several issues were discussed in debate form. The last panel was dedicated to discussion of three patients with computer assisted active participation of all the attendants. In addition, 03 abstracts were presented as posters, all of which were published in the Book of Abstracts. The organizing committee gratefully acknowledges the contributors who presented their work in clear and concise manner and the participants, whose active part in the discussions contributed to the success of the meeting. The Jerusalem International symposium on Inflammatory Bowel Diseases has become a tradition that will continue with the Fourth Symposium to be convened in September 1993. Joseph Zimmerman, M.D. Daniel Rachmi1ewitz, M.D. LIST OF FIRST AUTHORS Theodore M. Bayless, Michael J. Langman, Johns Hopkins University Department of Medicine, School of Medicine, Queen Elizabeth Hospital, Baltimore, Maryland. Birmingham, England. Michael D. Blackstone, J.E. Lennard-Jones, University of Chicago, St. Mark's Hospital, Chicago, Illinois. City Road, London, England. Charles O. Elson, Division of Gastroenterology, James Lee Madara, The University of Alabama Department of Pathology, at Birmingham, Brigham and Women's Hospital, Birmingham, Alabama. Boston, Massachusetts.
efficacy of oral mesalazine in Crohn's disease . Canad . J. Gastroenterol . 4 , 13–
18 ( 1990 ) . 185. Hanauer , S. B. The role of mesalazine in Crohn's disease .
Scand . J. Gastroenterol . 25 ( suppl . 172 ) , 56-9 ( 1990 ) . 186. Mahida , Y. R. ,
Author: F. T. De Dombal
Publisher: Oxford University Press, USA
This new edition of a major work on inflammatory bowel disease is edited by the team responsible for the multi-national inflammatory bowel disease survey conducted over the past twenty years by the Research Team of the World Organization of Gastroenterology. The book covers some of the majorissues concerning inflammatory bowel disease with contributions from an international panel of authors, each considerably experienced in the management of inflammatory bowel disease. This multi-national work contains unique data collected from some 4500 patients from over 20 countries worldwide,including an expanded central section dealing with the World Organization of Gastroenterology survey. This new edition of this successsful volume provides an unrivalled, international summary of the field.
Is IBD a genetic disease? In: Rachmilewitz D, Zimmerman J, editors.
Inflammatory bowel diseases 1990. Dordrecht: Kluwer, 1990:5–18. Rotter JI,
Yang H. Delineating the major aetiological risk factors for IBD: the genetic
Author: D. Rachmilewitz
This book contains state of the art reviews on the latest knowledge and approaches on the aetiopathogenesis, clinical assessment of disease activity, medical therapy, surgical therapy and postoperative recurrence of inflammatory bowel diseases. The chapters are derived from presentations at the Fourth Jerusalem International Symposium in Inflammatory Bowel Diseases, in conjunction with Falk Symposium No. 72, which was held in Strasbourg, France, in September 1993, and attended by one thousand physicians from fifty-one countries.
Long - term 6 - mercaptopurine treatment in adolescents with Crohn ' s disease .
Gastroenterology 1990 ; 99 : 1347 . 48 . Verhave M , Winter HS , Grand RJ :
Azathioprine in the treatment of children with inflammatory bowel disease . J
Author: Joseph B. Kirsner
Publisher: W.B. Saunders Company
World-renowned experts present state-of-the-art information in the clinical understanding of inflammatory bowel disease in the 5th Edition of this best-selling text. Scholarly and pragmatic, this text features authoritative information on the medical and surgical management of IBD with the support of over 390 illustrations. Features many new chapters, including those covering intestinal permeability in health and disease, the intestinal response to acute inflammation and injuries, and current concepts of IBD etiology and pathogenesis.
Gastroenterology 1990 ; 98 : A161 . 5 . de Dombal FT , Burton I , Goligher JC :
Recurrence of Crohn ' s disease after primary excisional surgery . Gut 1971 ; 12 :
517 – 527 . 6 . Farmer RG , Whelan G , Fazio WV : Long - term follow up of
Author: Burton I. Korelitz
Publisher: Mosby Incorporated
Overview & etiology; special considerations in diagnosis & mgmt.; surgery; drug therapy; surveillance in colitis.
1990 ; 98 : 269 - 77 . 10 . Banerjee AK , Peters TJ . Experimental non - steroidal
anti - inflammatory drug - induced enteropathy in the rat : similarities to
inflammatory bowel disease and effect of thromboxane synthetase inhibitors . Gut
. 1990 ...
Author: J. Schölmerich
Inflammatory bowel diseases are still a challenging problem in today's gastroenterology. Although their aetiology is still not understood, steady progress has been made recently in the understanding of their pathogenesis, due to the application of innovative molecular and cellular biological methods. Knowledge of the immunology of the gut and the basic mechanisms of inflammatory reactions, especially pro and anti-inflammatory mediators, the characterization of inflammatory cell types and their functions and molecules mediating cell interactions. This book closes the gap between new findings in pathophysiology and treatment in order to better understand our current therapeutic concepts and to develop new strategies for the future. It comprises the proceedings of the 67th Falk Symposium, held in Regensburg, June 1992, and contains sections on aetiology, pathophysiology, extra-intestinal mainfestations, diagnosis and treatment. It is essential reading for all clinicians treating IBD.
Free radicals and other reactive oxygen metabolites in inflammatory bowel
disease : cause , consequence , or ... Inflammation . 1990 ; 10 : 1-12 . 9.
Klebanoff SJ . Oxygen metabolites from phagocytes . In : Gallen JI , Goldstein IM ,
Author: E. Monteiro
This volume contains the proceedings of Falk Symposium No. 76, held in Estoril, Portugal, May 5--7, 1994, and presents a modern aetiopathogenesis-based approach to clinical, diagnostic and therapeutic developments in inflammatory bowel disease. The first section deals with the first results of a prospective epidemiological study in the EEC countries, while subsequent sections cover the most important factors responsible for IBD, diagnosis, controversies in clinical management, new insights into therapy, and difficult clinical problems. The book closes with a state-of-the-art overview of the new knowledge as well as future perspectives regarding diagnosis and treatment. It will be of interest to all clinicians and researchers in this important area of gastroenterology.
Author: Charles Bernstein
Publisher: Remedica Pub Limited
This book will provide an update of the past year in inflammatory bowel disease, and covers selected topics that are important to clinical research and clinical management. The authors are six internationally regarded authorities in this area. The short, easy-to-read and up-to-date format makes this title unique in this field of medicine.
Crohn ' s Disease Rutgeerts P , Geboes K , Vantrappen G , Beyls J , Kerremans R
, Hiele M : Predictability of the postoperative course of Crohn ' s disease .
Gastroenterology 1990 ; 99 : 956 – 963 . One of the studies that emphasizes the
Author: Henry D. Janowitz
Publisher: Oxford University Press, USA
Janowitz crystallizes his conceptual and therapeutic approaches to the study of these crippling and enigmatic disorders and offers his advice on their daily management. He also discusses special considerations such as problems in diagnosis, pregnancy, cancer, extraintestinal manifestations of IBD, nutrition, and the role of psychotherapy.
Barton JR , Ferguson A. Clinical features , morbidity and mortality of Scottish
children with inflammatory bowel disease . Q J Med . 1990 ; 75 : 423-439 . 56.
Jess T , Gamborg M , Matzen P , Munkholm P , Sorensen TI . Increased risk of
Author: Ellen J. Scherl
Publisher: SLACK Incorporated
The Changing World of Inflammatory Bowel Disease: Impact of Generation, Gender, and Global Trends by Dr. Ellen J. Scherl and Dr. Marla C. Dubinsky looks to continue the progress made in recent years in the treatment given to patients with IBD by creating a timeline and individualized plan of action beginning with the onset of the disease and continuing throughout the life cycle of the patient. This unique and necessary text describes the important advancements in understanding the disease’s pathogenesis, epidemiology and natural history. The Changing World of Inflammatory Bowel Disease: Impact of Generation, Gender, and Global Trends also battles the tough questions such as the age of onset, the influence of the environment, and genetic factors. Sections Inside: • Introduction to the Life Cycle of IBD • IBD and the Pediatric Patient • IBD and the Young Adult • IBD and the Elderly • Special Considerations in the Management of the IBD life cycle Some Chapter Topics Include: • Pregnancy • Transitioning the adolescent • Emerging populations • Genetics Dr. Ellen J. Scherl and Dr. Marla C. Dubinsky are joined by over 20 of the world’s leading experts, making the The Changing World of Inflammatory Bowel Disease: Impact of Generation, Gender, and Global Trends, the definitive resource for the diagnosis, treatment, and individualized management plan throughout the life of each patient.